SCHEMBL7582040

SCHEMBL7582040

CCOC(=O)c1cn(C2CC2)c2nc(Cl)c(C)cc2c1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 1/20 0.44
▸ POLB P06746 2/20 0.41
▸ BAZ2B Q9UIF8 1/20 0.39
▸ BAZ2A Q9UIF9 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ AKR1C3 P42330 1/20 0.39
▸ AKR1C2 P52895 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ MAPT P10636 2/20 0.39
▸ DPP4 P27487 2/20 0.39
▸ CHRM2 P08172 1/20 0.39
▸ DRD1 P21728 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ ROCK2 O75116 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ PRKACA P17612 1/20 0.38
▸ CDK2 P24941 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10473152 0.91 ADRB2 (0.44) ADRB2POLBBAZ2BBAZ2ALMNA
SCHEMBL5422476 0.89 ADRB2 (0.51) ADRB2LMNAALDH1A1MAPTDPP4
SCHEMBL7551608 0.83 ALDH1A1 (0.44) ADRB2POLBLMNAALDH1A1MAPT
SCHEMBL5809336 0.83 ADRB2 (0.53) ADRB2LMNAALDH1A1MAPTDPP4
SCHEMBL10987423 0.83 ADRB2 (0.42) ADRB2POLBBAZ2BBAZ2AALDH1A1
SCHEMBL7231247 0.81 ADRB2 (0.46) ADRB2POLBBAZ2BBAZ2ALMNA
SCHEMBL9269551 0.81 KDM4E (0.44) ADRB2POLBBAZ2BBAZ2ALMNA
SCHEMBL9289170 0.81 KDM4E (0.44) ADRB2POLBBAZ2BBAZ2ALMNA
SCHEMBL8942057 0.80 ADRB2 (0.49) ADRB2LMNAALDH1A1MAPTDPP4
SCHEMBL7576170 0.80 STAT3 (0.44) ADRB2POLBBAZ2BBAZ2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020049223-A1 Quinoline and naphthyridine carboxylic acid antibacterials ABBOTT LABORATORIES 2002-04-25 — — US claimed
US-20020049223-A1 Quinoline and naphthyridine carboxylic acid antibacterials ABBOTT LABORATORIES 2002-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020049223-A1 Quinoline and naphthyridine carboxylic acid antibacterials NQO2, NQO1, NDUFA7 ADRB2 3198/4885POLB 692/4885BAZ2B 4539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback